GenomeQuest has appointed Robert Hoyt as an independent director of the firm. Hoyt is currently the COO of Eximo. Previously, he was general manager of Endeco Technologies, which sold to Oracle in 2011. He has held executive roles at both start up and publicly held software companies.
Paired Ends: Robert Hoyt
Premium